GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (STU:39K) » Definitions » Piotroski F-Score

Centogene NV (STU:39K) Piotroski F-Score : 4 (As of Dec. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Centogene NV has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Centogene NV's Piotroski F-Score or its related term are showing as below:

STU:39K' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 4
Current: 4

During the past 8 years, the highest Piotroski F-Score of Centogene NV was 4. The lowest was 2. And the median was 4.


Centogene NV Piotroski F-Score Historical Data

The historical data trend for Centogene NV's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Piotroski F-Score Chart

Centogene NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A 4.00 2.00 3.00 4.00

Centogene NV Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 3.00 5.00 4.00

Competitive Comparison of Centogene NV's Piotroski F-Score

For the Diagnostics & Research subindustry, Centogene NV's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centogene NV's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Centogene NV's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Mar22) TTM:
Net Income was -10.348 + 0 + 0 + 0 = €-10.35 Mil.
Cash Flow from Operations was -5.249 + 0 + 0 + 0 = €-5.25 Mil.
Revenue was 11.198 + 0 + 0 + 0 = €11.20 Mil.
Gross Profit was 4.612 + 0 + 0 + 0 = €4.61 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Dec23) was
(108.102 + 90.163 + 92.812 + 71.892 + 77.155) / 5 = €88.0248 Mil.
Total Assets at the begining of this year (Mar22) was €108.10 Mil.
Long-Term Debt & Capital Lease Obligation was €52.28 Mil.
Total Current Assets was €44.02 Mil.
Total Current Liabilities was €43.37 Mil.
Net Income was -8.356 + -21.644 + -11.693 + -6.482 = €-48.18 Mil.

Revenue was 9.209 + 30.196 + -104.793 + 10.327 = €-55.06 Mil.
Gross Profit was 2.592 + -5.422 + -2.203 + 3.877 = €-1.16 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was
(145.434 + 120.786 + 96.19 + 91.136 + 108.102) / 5 = €112.3296 Mil.
Total Assets at the begining of last year (Mar21) was €145.43 Mil.
Long-Term Debt & Capital Lease Obligation was €36.43 Mil.
Total Current Assets was €71.30 Mil.
Total Current Liabilities was €28.70 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Centogene NV's current Net Income (TTM) was -10.35. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Centogene NV's current Cash Flow from Operations (TTM) was -5.25. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=-10.348/108.102
=-0.09572441

ROA (Last Year)=Net Income/Total Assets (Mar21)
=-48.175/145.434
=-0.33124991

Centogene NV's return on assets of this year was -0.09572441. Centogene NV's return on assets of last year was -0.33124991. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Centogene NV's current Net Income (TTM) was -10.35. Centogene NV's current Cash Flow from Operations (TTM) was -5.25. ==> -5.25 > -10.35 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Dec23
=52.279/88.0248
=0.59391217

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=36.43/112.3296
=0.32431345

Centogene NV's gearing of this year was 0.59391217. Centogene NV's gearing of last year was 0.32431345. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=44.019/43.366
=1.01505788

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=71.301/28.698
=2.48452854

Centogene NV's current ratio of this year was 1.01505788. Centogene NV's current ratio of last year was 2.48452854. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Centogene NV's number of shares in issue this year was 28.163. Centogene NV's number of shares in issue last year was 23.15. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4.612/11.198
=0.41185926

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-1.156/-55.061
=0.0209949

Centogene NV's gross margin of this year was 0.41185926. Centogene NV's gross margin of last year was 0.0209949. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=11.198/108.102
=0.10358735

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=-55.061/145.434
=-0.37859785

Centogene NV's asset turnover of this year was 0.10358735. Centogene NV's asset turnover of last year was -0.37859785. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Centogene NV has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Centogene NV  (STU:39K) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Centogene NV Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Centogene NV's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Centogene NV Business Description

Traded in Other Exchanges
Address
Am Strande 7, Rostock, MV, DEU, 18055
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV Headlines

No Headlines